Lux Health Tech Acquisition (Lux Health Tech Acquisition) Cash And Cash Equivalents : $0.03 Mil (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Lux Health Tech Acquisition Cash And Cash Equivalents?

Lux Health Tech Acquisition's quarterly cash and cash equivalents declined from Dec. 2021 ($0.42 Mil) to Mar. 2022 ($0.13 Mil) but then stayed the same from Mar. 2022 ($0.13 Mil) to Jun. 2022 ($0.03 Mil).

Lux Health Tech Acquisition's annual cash and cash equivalents increased from . 20 ($0.00 Mil) to Dec. 2020 ($0.64 Mil) but then declined from Dec. 2020 ($0.64 Mil) to Dec. 2021 ($0.42 Mil).

Lux Health Tech Acquisition Cash And Cash Equivalents Historical Data

The historical data trend for Lux Health Tech Acquisition's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lux Health Tech Acquisition Cash And Cash Equivalents Chart

Lux Health Tech Acquisition Annual Data

Trend

Dec20

Dec21

Cash And Cash Equivalents

0.64

0.42

Lux Health Tech Acquisition Quarterly Data
	Aug20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Cash And Cash Equivalents	Get a 7-Day Free Trial			0.28	0.13	0.42	0.13	0.03

Lux Health Tech Acquisition Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Lux Health Tech Acquisition (NAS:LUXAU) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Lux Health Tech Acquisition Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Lux Health Tech Acquisition's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXAU) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

920 Broadway, 11th Floor, New York, NY, USA, 10010

Website

https://www.luxcapital.com

Lux Health Tech Acquisition Corp is a blank check company.

Executives

Frederic H Moll	director	C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Joshua Defonzo	director, officer: Chief Executive Officer	1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070
Peter Hebert	director, 10 percent owner	C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017
J Robert Kerrey	director	NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Josh Wolfe	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Bijan Salehizadeh	director	C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005
Segolene Scarborough	officer: CFO and Treasurer	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Sponsor, Lp	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Holdings, Llc	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines

From GuruFocus

Lux Health Tech Acquisition Corp. Announces Closing of $345 Million Initial Public Offering

By Business Wire Business Wire • 10-29-2020

Lux Health Tech Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 14, 2020

By Business Wire Business Wire • 12-11-2020